Biodistribution and dosimetry of the investigational PET agent 68Ga-P16-093 in prostate cancer patients with biochemical recurrence undergoing clinical 68Ga-PSMA-11 PET/CT
Recruiting
18 years - 100 years
Male
Phase
N/A
1 Location
Brief description of study
Whole body biodistribution and dosimetry with preliminary comparison to PSMA-11 in prostate cancer patients with biochemical recurrence
Detailed description of study
The primary purpose of the present research project is to determine the biodistribution of 68Ga-P16-093 in prostate cancer patients, and to assess associated patient radiation exposure based on our PET measures of organ uptake as a function of time. A secondary goal is to conduct a preliminary evaluation of the sensitivity and specificity of 68Ga-P16-093 compared to 68Ga-PSMA-11 to detect local or distant sites of recurrent disease.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: prostate cancer
-
Age: 18 years - 100 years
-
Gender: Male
Inclusion Criteria
Prostate cancer patients presenting with rising PSA after radical prostatectomy for treatment if primary disease
Histologically confirmed prostate cancer with following Gleason scoring at biopsy
Scheduled for radical prostatectomy (expected to occur within 60-days of scanning)
Exclusion Criteria
Exclusion Criteria
Patient is unable to tolerate remaining still on the bed of the PET camera, due to physical limitations or claustrophobia
Significant acute or chronic medical, neurologic, or illness in the subject that, in the judgment of the Clinical Investigators, could compromise subject safety, limit the ability to complete the study, and/or compromise the objectives of the study
Updated on
04 Aug 2024.
Study ID: 1711061247 (RADY-FIVEELEV-GREEN-GA)
Find a site
,
Your Information has been sent successfully.
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up
Send a message
Enter your contact details to connect with study team
Primary Contact
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
Please choose between Voice or SMS based delivery of verification code
or